M. Swarajya Lakshmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. Swarajya Lakshmi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aarthi Vara
Mamata Acad Med Sci, Dept Microbiol, Hyderabad, Telangana, India
2 shared publications - Kalyani Kuruva
Mamata Acad Med Sci, Dept Microbiol, Hyderabad, Telangana, India
2 shared publications - Koppala Rekha
PHD Scholar, Department of Microbiology, Saveetha medical college, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Thandalam, Chennai 600077, Tamil Nadu, Tutor, Department of Microbiology, Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana, India
1 shared publication - Mudhigeti Nagaraja
Department of Microbiology, Sri Balaji Medical College Hospital and Research Institute, Renigunta, Tirupati, Andhra Pradesh 517520, India
1 shared publication - Mukesh Kumar Dharmalingam Jothinathan
Centre for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India
1 shared publication - Shilpa Pradhan
Mamata Acad Med Sci, Dept Microbiol, Hyderabad, Telangana, India
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (2) , 1121
Carbapenem-resistant Acinetobacter: A Review of Resistance Mechanisms, Global Trends, and Control Strategies
Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant healthcare challenge worldwide because of its role in bloodstream infections, wound infections, and ventilator-associated pneumonia. A particularly concerning trait is its ability to develop multidrug-resistance and its unique capacity to endure extreme conditions that other microorganisms cannot withstand. This review delves into the microbiology of Acinetobacter spp., exploring their characteristics, molecular classification, and mechanisms of carbapenem-resistance, including the production of carbapenem-hydrolyzing β-lactamases (notably Oxacillinase (OXA-type), efflux pump activity, alterations in porin channels, and horizontal gene transfer. This paper emphasizes the rapid global dissemination of Acinetobacter spp. due to antibiotic misuse and improper treatment methods. Research also reveals that treatment options for these infections are severely limited, necessitating the development of new and innovative treatment strategies. To curb the spread of Acinetobacter spp., there is a pressing need to focus on advancements in diagnostics, control measures, antimicrobial stewardship programs, and new therapies such as vaccines and phage therapy. It is crucial to enhance disease diagnostics, invest in research and development of effective new drugs, and collaborate internationally to share knowledge about CRAB.
- 1 June 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (2) , 1121
Open AccessCarbapenem-resistant Acinetobacter: A Review of Resistance Mechanisms, Global Trends, and Control Strategies
Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant healthcare challenge worldwide because of its role in bloodstream infections, wound infections, and ventilator-associated pneumonia. A particularly concerning trait is its ability to develop multidrug-resistance and its unique capacity to endure extreme conditions that other microorganisms cannot withstand. This review delves into the microbiology of Acinetobacter spp., exploring their characteristics, molecular classification, and mechanisms of carbapenem-resistance, including the production of carbapenem-hydrolyzing β-lactamases (notably Oxacillinase (OXA-type), efflux pump activity, alterations in porin channels, and horizontal gene transfer. This paper emphasizes the rapid global dissemination of Acinetobacter spp. due to antibiotic misuse and improper treatment methods. Research also reveals that treatment options for these infections are severely limited, necessitating the development of new and innovative treatment strategies. To curb the spread of Acinetobacter spp., there is a pressing need to focus on advancements in diagnostics, control measures, antimicrobial stewardship programs, and new therapies such as vaccines and phage therapy. It is crucial to enhance disease diagnostics, invest in research and development of effective new drugs, and collaborate internationally to share knowledge about CRAB.
- Open Access
- 13 October 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (4) , 2111-2118
Phenotypic Detection of Carbapenemase Production in Gram Negative Bacilli from Clinical Isolates in a Tertiary Care Hospital in Telangana
- 13 October 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (4) , 2111-2118
Open AccessPhenotypic Detection of Carbapenemase Production in Gram Negative Bacilli from Clinical Isolates in a Tertiary Care Hospital in Telangana